Cardinal Health, Inc. (CAH) Guidance & Earnings Results
On 2026-08-11 Cardinal Health, Inc. raised guidance: "FY27 non-GAAP EPS $12.40-12.60 (+13-15% growth); Pharma segment revenue +3-5%, profit +8-11%; GMPD segment revenue +2-4%, profit $200-220M; Other segment revenue +11-13%, profit +15-18%; Interest and other $240-290M;…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CAHCardinal Health, Inc.Follow CAH — free
—
Price chart with a free account
- Market cap
- 58.0B
- P/E TTM
- 34.5
- Dividend yield
- 0.8%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 11 Aug 26 | Raised | FY27 non-GAAP EPS $12.40-12.60 (+13-15% growth); Pharma segment revenue +3-5%, profit +8-11%; GMPD segment revenue +2-4%, profit $200-220M; Other segment revenue +11-13%, profit +15-18%; Interest and other $240-290M; Non-GAAP tax rate 19-20%; Diluted shares ~233M; Share repurchases ~$1B; Capex ~$700M; Adjusted free cash flow $3.5-4.0B · full year |
| 30 Apr 26 | Raised | FY26 non-GAAP EPS guidance raised to $10.70-$10.80 from prior range · full year |
| 5 Feb 26 | Raised | FY2026 non-GAAP EPS raised to $10.15-$10.35 from prior $9.65-$9.85 · full year |
| 30 Oct 25 | Raised | Non-GAAP EPS raised to $9.65-$9.85 from $9.30-$9.50; adjusted FCF raised to $3.0-$3.5B from $2.75-$3.25B · full year |
| 12 Aug 25 | Raised | FY2026 non-GAAP diluted EPS guidance raised to $9.30-$9.50 from $9.10-$9.30; Pharmaceutical segment revenue +11-13% growth; segment profit +11-13% growth; GMPD segment revenue +2% growth · full year |
Cardinal Health, Inc. — questions
- What guidance did Cardinal Health, Inc. give?
- On 2026-08-11: "FY27 non-GAAP EPS $12.40-12.60 (+13-15% growth); Pharma segment revenue +3-5%, profit +8-11%; GMPD segment revenue +2-4%, profit $200-220M; Other segment revenue +11-13%, profit +15-18%; Interest and other $240-290M; Non-GAAP tax rate 19-20%; Diluted shares ~233M; Share repurchases ~$1B; Capex ~$700"
- When does Cardinal Health, Inc. report earnings?
- Cardinal Health, Inc.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from Cardinal Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.